179 related articles for article (PubMed ID: 35084435)
1. Role of Endothelin-1 Receptors in Limiting Leg Blood Flow and Glucose Uptake During Hyperinsulinemia in Type 2 Diabetes.
Young BE; Padilla J; Finsen SH; Fadel PJ; Mortensen SP
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35084435
[TBL] [Abstract][Full Text] [Related]
2. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
3. The role of endothelin A receptors in peripheral vascular control at rest and during exercise in patients with hypertension.
Craig JC; Broxterman RM; La Salle DT; Cerbie J; Ratchford SM; Gifford JR; Bunsawat K; Nelson AD; Bledsoe AD; Morgan DE; Wray DW; Richardson RS; Trinity JD
J Physiol; 2020 Jan; 598(1):71-84. PubMed ID: 31705661
[TBL] [Abstract][Full Text] [Related]
4. Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors.
Bellien J; Iacob M; Monteil C; Rémy-Jouet I; Roche C; Duflot T; Vendeville C; Gutierrez L; Thuillez C; Richard V; Joannidès R
J Hypertens; 2017 Jun; 35(6):1204-1212. PubMed ID: 28441692
[TBL] [Abstract][Full Text] [Related]
5. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
[TBL] [Abstract][Full Text] [Related]
6. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit.
Maurice MC; Gratton JP; D'Orléans-Juste P
Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126
[TBL] [Abstract][Full Text] [Related]
9. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated vascular and metabolic actions of endothelin-1 in canine small intestine.
King-VanVlack CE; Mewburn JD; Chapler CK
Am J Physiol; 1999 May; 276(5):G1131-6. PubMed ID: 10330003
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
[TBL] [Abstract][Full Text] [Related]
12. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
13. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of pulmonary artery contraction induced by endothelin-B receptor antagonism.
Fukuroda T; Nishikibe M
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S169-71. PubMed ID: 9595429
[TBL] [Abstract][Full Text] [Related]
15. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Miyauchi T; Ishikawa S; Onizuka M; Goto K; Nishikibe M
Br J Pharmacol; 1996 Mar; 117(6):995-9. PubMed ID: 8882588
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.
Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ
Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538
[TBL] [Abstract][Full Text] [Related]
17. Role of endothelin in the increased vascular tone of patients with essential hypertension.
Cardillo C; Kilcoyne CM; Waclawiw M; Cannon RO; Panza JA
Hypertension; 1999 Feb; 33(2):753-8. PubMed ID: 10024340
[TBL] [Abstract][Full Text] [Related]
18. Endothelin ET
Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
[TBL] [Abstract][Full Text] [Related]
19. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
